| pubmed-article:2719649 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:2719649 | lifeskim:mentions | umls-concept:C0017973 | lld:lifeskim |
| pubmed-article:2719649 | lifeskim:mentions | umls-concept:C0006681 | lld:lifeskim |
| pubmed-article:2719649 | lifeskim:mentions | umls-concept:C0021467 | lld:lifeskim |
| pubmed-article:2719649 | lifeskim:mentions | umls-concept:C0010423 | lld:lifeskim |
| pubmed-article:2719649 | lifeskim:mentions | umls-concept:C0021469 | lld:lifeskim |
| pubmed-article:2719649 | lifeskim:mentions | umls-concept:C0205686 | lld:lifeskim |
| pubmed-article:2719649 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:2719649 | pubmed:dateCreated | 1989-6-15 | lld:pubmed |
| pubmed-article:2719649 | pubmed:abstractText | Of a range of glycosaminoglycans, heparin and heparan sulphate were the most effective inhibitors in vitro of CaCO3 (calcite) crystallization as assayed by conductimetric measurements. The possible role of such glycosaminoglycans in modulating calcium-salt crystallizations in vivo is discussed. | lld:pubmed |
| pubmed-article:2719649 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2719649 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2719649 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2719649 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2719649 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2719649 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2719649 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2719649 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2719649 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2719649 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2719649 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2719649 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2719649 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2719649 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2719649 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2719649 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2719649 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2719649 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2719649 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2719649 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2719649 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2719649 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2719649 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2719649 | pubmed:language | eng | lld:pubmed |
| pubmed-article:2719649 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2719649 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:2719649 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2719649 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2719649 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2719649 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:2719649 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:2719649 | pubmed:month | Apr | lld:pubmed |
| pubmed-article:2719649 | pubmed:issn | 0264-6021 | lld:pubmed |
| pubmed-article:2719649 | pubmed:author | pubmed-author:WilliamsonF... | lld:pubmed |
| pubmed-article:2719649 | pubmed:author | pubmed-author:GrantDD | lld:pubmed |
| pubmed-article:2719649 | pubmed:author | pubmed-author:LongW FWF | lld:pubmed |
| pubmed-article:2719649 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:2719649 | pubmed:day | 1 | lld:pubmed |
| pubmed-article:2719649 | pubmed:volume | 259 | lld:pubmed |
| pubmed-article:2719649 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:2719649 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:2719649 | pubmed:pagination | 41-5 | lld:pubmed |
| pubmed-article:2719649 | pubmed:dateRevised | 2010-9-10 | lld:pubmed |
| pubmed-article:2719649 | pubmed:meshHeading | pubmed-meshheading:2719649-... | lld:pubmed |
| pubmed-article:2719649 | pubmed:meshHeading | pubmed-meshheading:2719649-... | lld:pubmed |
| pubmed-article:2719649 | pubmed:meshHeading | pubmed-meshheading:2719649-... | lld:pubmed |
| pubmed-article:2719649 | pubmed:meshHeading | pubmed-meshheading:2719649-... | lld:pubmed |
| pubmed-article:2719649 | pubmed:meshHeading | pubmed-meshheading:2719649-... | lld:pubmed |
| pubmed-article:2719649 | pubmed:year | 1989 | lld:pubmed |
| pubmed-article:2719649 | pubmed:articleTitle | Inhibition by glycosaminoglycans of CaCO3 (calcite) crystallization. | lld:pubmed |
| pubmed-article:2719649 | pubmed:affiliation | Department of Biochemistry, University of Aberdeen, Marischal College, Scotland, U.K. | lld:pubmed |
| pubmed-article:2719649 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:2719649 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
